NEW YORK (GenomeWeb News) – The Dana-Farber Cancer Institute plans to install a Helicos Genetic Analysis System this month, GenomeWeb Daily News sister publication In Sequence has learned.
The instrument is scheduled to be shipped from Helicos BioSciences later this week.
Under an agreement with Helicos, Dana-Farber will have the instrument on site for six months free of charge.
During that time, researchers from 12 institute labs are planning to run a total of 600 samples — 50 samples every two weeks — for applications that include ChIP-Seq and digital gene expression analysis of samples involved in cancer, according to Paul Morrison, director of molecular biology core facilities at DFCI. The labs are paying for reagents required for these projects.
Projects will start "as soon as we get [the instrument] off the elevator," according to Morrison.